874

ULTRA-DEEP PACBIO SEQUENCING REVEALS THE FEATURES AND GENOMIC FUNCTION OF GUT VIRUSES IN COLORECTAL CANCER BASED ON 23992 VIRUS GENOMES

Date
May 20, 2024
Explore related products in the following collection:

Background and Aims: Dysbiosis of gut virus community is associated with colorectal cancer (CRC), but viral features and genomic function remain unclear. In this study, we aimed to uncover the gut virus lifestyle, gene function, single nucleotide polymorphism (SNP) and structural variation (SV), abundance and phage-host interaction in CRC based on assembled gut virus genomes.

Methods: Faecal samples were collected from CRC patients (n=11) and healthy controls (n=10), followed by virus-like particle (VLP) isolation. Extracted VLP DNA (length > 15 kb, at least 10 μg / sample) was directly sequenced using PacBio sequencing platforms. Gut virus genomes were assembled and annotated using Canu and EggNog. Differential abundance viruses were analyzed using DEseq2. SNP/SV were analyzed using MetaPop and Sniffles2. The host of virus was predicted using iPHoP.

Results: A total of 23,992 high-quality gut virus genomes were assembled, including 9045 novel virus genomes. More novel viruses were detected in CRC (41.23%) compared to healthy control (34.44%). The proportion of phages, especially temperate phages was significantly higher in CRC (37.29%) than in healthy control (33.71%) (P < 0.001). Based on the KEGG pathway analyses of virus genes, we identified the enrichment of pathways in CRC, including DNA repair and recombination, homologous recombination and mismatch repair pathways compared to healthy control. In addition, we found 71 viruses showed significantly higher SNPs in CRC compared to healthy control (P < 0.05). A total of 2025 virus genes showed higher frequency of SNPs in CRC compared to healthy control. Among them, 15 genes with differential SNPs could distinguish CRC from healthy control with an AUC of 88.03% using a random forest model. Moreover, 15differential abundance viruses could distinguish CRC from healthy control with an AUC of 94.12% in our training cohort. Its performance was validated in five global cohorts with AUCs of 71.94%-81.72%. Finally, we found that gut phage-host bacteria interaction was greatly altered in CRC compared to healthy control, which involving CRC-associated bacteria, such as Bacteroides fragilis and Fusobacterium nucleatum. Especially, both the genome number (68) and relative abundance (4.28%) of B. fragilis-hosted phages were significantly lower in CRC than in healthy control (129 and 4.86%, P < 0.05).

Conclusions: Multidimensional analysis based on PacBio sequencing demonstrated that gut virus communities, lifestyle, gene function, SNP/SV and phage-host interaction were significantly altered in CRC patients as compared to healthy control. Gut virus abundance and SNPs are potential biomarkers for the diagnosis of CRC.

Tracks

Related Products

Thumbnail for THE EFFECT OF GUT MICROBIOTA ON IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF PAN-CANCER AND NOVEL MICROBIAL BIOMARKERS FOR PREDICTING THERAPEUTIC RESPONSE
THE EFFECT OF GUT MICROBIOTA ON IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF PAN-CANCER AND NOVEL MICROBIAL BIOMARKERS FOR PREDICTING THERAPEUTIC RESPONSE
The gut microbiota is closely related to cancer patient response to immune checkpoint inhibitors (ICI). However, there are inconsistencies in species affecting ICI efficacy, whilst the role of non-bacterial microbes in immunotherapy remains elusive…
Thumbnail for RNA N6-METHYLADENOSINE ERASER ALKBH5 DRIVES STEMNESS AND CHEMORESISTANCE OF COLORECTAL CANCER THROUGH A M6A-FAM84A-Β-CATENIN AXIS
RNA N6-METHYLADENOSINE ERASER ALKBH5 DRIVES STEMNESS AND CHEMORESISTANCE OF COLORECTAL CANCER THROUGH A M6A-FAM84A-Β-CATENIN AXIS
BACKGROUND: RNA N6-methyladenoine (m6A) modification plays multifaceted roles in cancer, including tumor initiation, progression and therapy resistance. Nevertheless, the role of aberrant m6A in cancer stem cells (CSCs) remains unclear…
Thumbnail for A BLOOD-BASED BIOMARKER PANEL FOR NON-INVASIVE DIAGNOSIS OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
A BLOOD-BASED BIOMARKER PANEL FOR NON-INVASIVE DIAGNOSIS OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form metabolic dysfunction-associated steatohepatitis (MASH) are highly prevalent worldwide. However, current non-invasive diagnostic approaches for MASLD and MASH are suboptimal…
Thumbnail for TUMOR-RESIDENT PROBIOTIC CLOSTRIDIUM BUTYRICUM FACILITATES IMMUNE THERAPY IN COLORECTAL CANCER BY TARGETING SECD-GRP78 AXIS
TUMOR-RESIDENT PROBIOTIC CLOSTRIDIUM BUTYRICUM FACILITATES IMMUNE THERAPY IN COLORECTAL CANCER BY TARGETING SECD-GRP78 AXIS
BACKGROUND: _Clostridium butyricum_ is a known probiotic bacterium with anti-inflammatory activity. We found that it is depleted in patients with colorectal cancer (CRC) from multiple cohorts. Here, we examined the immunomodulatory effect of _C…